Asset Dedication LLC’s VanEck Pharmaceutical ETF PPH Stock Holding History

Asset Dedication LLC’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-214	Closed	-$16K	–	1039
2021 Q4	$16K	Hold	214	–	–	﹤0.01%	583
2021 Q3	$16K	Buy	214 +67	+46%	+$5K	﹤0.01%	611
2021 Q2	$11K	Hold	147	–	–	﹤0.01%	610
2021 Q1	$10K	Hold	147	–	–	﹤0.01%	508
2020 Q4	$10K	Hold	147	–	–	﹤0.01%	561
2020 Q3	$9K	Hold	147	–	–	﹤0.01%	544
2020 Q2	$9K	Buy	+147	New	+$8.89K	﹤0.01%	475
2019 Q2	–	Sell	-168	Closed	-$10K	–	623
2019 Q1	$10K	Hold	168	–	–	﹤0.01%	448
2018 Q4	$9K	Hold	168	–	–	﹤0.01%	438
2018 Q3	$11K	Hold	168	–	–	﹤0.01%	430
2018 Q2	$10K	Hold	168	–	–	﹤0.01%	448
2018 Q1	$10K	Hold	168	–	–	0.01%	376
2017 Q4	$10K	Hold	168	–	–	﹤0.01%	359
2017 Q3	$10K	Hold	168	–	–	﹤0.01%	294
2017 Q2	$10K	Buy	+168	New	+$9.51K	0.01%	307
2017 Q1	–	Sell	-168	Closed	-$9K	–	390
2016 Q4	$9K	Buy	+168	New	+$8.98K	0.01%	306

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LJAC

L.J. Altfest & Co New York $935M AUM 27.19% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

TPWM

Twelve Points Wealth Management Concord, Massachusetts $455M AUM 19.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Asset Dedication LLC's PPH Position: Q1 2022 in Review

Asset Dedication LLC sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2022, closing a stake of 214 shares — an estimated $16K sold.

Asset Dedication LLC first reported a position in PPH in Q4 2016 and held it in 16 quarters. The position peaked at $16K in Q4 2021. 75 funds tracked by Wall St. Rank hold PPH as of Q1 2022.

Asset Dedication LLC reported no remaining VanEck Pharmaceutical ETF position as of Q1 2022 after selling out during the quarter.
Asset Dedication LLC sold 214 VanEck Pharmaceutical ETF shares in Q1 2022, an estimated $16K.
Asset Dedication LLC first reported a position in VanEck Pharmaceutical ETF in Q4 2016 and held it in 16 quarters.
Asset Dedication LLC's VanEck Pharmaceutical ETF position peaked at $16K in Q4 2021.
75 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2022.

Based on Asset Dedication LLC's 13F filing for Q1 2022, filed 21 Apr 2022.